Largest ever Parkinson’s research trial is starting now
Date
News
Date
Research shows that deep brain stimulation may help boost energy levels in Parkinson’s brain cells by increasing the size of mitochondria.
Date
The pioneering GDNF clinical trials programme delivered an experimental treatment directly to the brain. The trial results offer hope that it may be possible to restore the cells damaged in Parkinson’s.
Date
Researchers at King’s College London are starting a world-first clinical trial to test if a probiotic drink could help with motor and non-motor symptoms of Parkinson's.
Date
New report on services in Scotland.
Date
A clinical trial has produced further evidence that there is no benefit of delaying levodopa therapy.
Date
We’re investing a further £1.5million to advance pioneering drug discovery work to develop new molecules that can both improve symptoms and slow progression.
Date
European study suggests that smoking has a protective role to reduce the risk of developing Parkinson's.
Date
Scientists have identified a key molecule - called USP13 - which may provide a new avenue to prevent the build up of alpha-synuclein in brain cells.
Date
A US study has found that people with Attention-Deficit Hyperactivity Disorder (ADHD) may have an increased risk of developing Parkinson's.
Date
In August 2018, Kyle Alexander was appointed by co-option to the Board of Trustees, bringing a Northern Ireland presence to the board.